next
gener
sequenc
ng
technolog
revolution
genom
field
becom
commonplac
identif
human
infecti
diseas
howev
due
low
abund
viral
nucleic
acid
na
relat
host
viral
identif
use
direct
ng
technolog
often
lack
suffici
sensit
describ
approach
base
two
complementari
enrich
strategi
significantli
improv
sensit
ngsbase
viru
identif
start
develop
two
set
dna
probe
enrich
viru
na
associ
respiratori
diseas
first
set
probe
span
genom
allow
identif
known
virus
full
genom
sequenc
second
set
target
region
conserv
among
viral
famili
genera
provid
abil
detect
known
potenti
novel
member
viru
group
effici
enrich
assess
ng
test
refer
viru
clinic
sampl
known
infect
show
signific
improv
viral
identif
use
enrich
ng
compar
unenrich
ng
without
enrich
observ
averag
target
viral
read
per
sampl
howev
enrich
read
per
sampl
target
viral
read
refer
isol
clinic
specimen
use
probe
set
importantli
dramat
improv
genom
coverag
also
observ
follow
virusspecif
probe
enrich
method
describ
provid
improv
sensit
viru
identif
ng
allow
comprehens
analysi
diseas
etiolog
supplement
materi
avail
articl
numer
infecti
diseas
includ
acut
lower
respiratori
tract
ill
go
undiagnos
garau
calbo
failur
detect
may
result
limit
repertoir
routin
diagnost
inabl
commonli
use
pcr
method
pick
variant
known
pathogen
unknown
previous
unrecogn
pathogen
use
next
gener
sequenc
ng
viral
detect
discoveri
provid
signific
advantag
tradit
viral
diagnost
assaysful
genom
sequenc
may
obtain
target
limit
preexist
knowledg
pathogen
howev
one
greatest
challeng
ng
routin
afford
diagnost
tool
rel
pauciti
viral
nucleic
acid
na
present
clinic
sampl
effort
increas
proport
viral
sequenc
obtain
ng
sever
techniqu
nonsequencespecif
viral
enrich
implement
ultracentrifug
sampl
filtrat
viral
cultur
use
enrich
viral
particl
prior
nucleic
acid
extract
breitbart
rohwer
duhaim
sullivan
addit
host
genom
dna
deplet
dnase
treatment
ribosom
rna
deplet
use
reduc
level
host
na
sampl
alland
et
al
although
method
show
modest
level
improv
detect
viral
target
sequenc
read
achiev
desir
sensit
altern
sequencespecif
approach
involv
hybridizationbas
sequenc
captur
specif
na
use
dna
rna
probe
lovett
et
al
albert
et
al
hodg
et
al
okou
et
al
sever
group
employ
method
virusspecif
captur
genom
enrich
prior
ng
depledg
et
al
mate
et
al
olp
et
al
use
sureselect
xt
target
enrich
system
depledg
et
al
enrich
human
herpesvirus
clinic
sampl
find
signific
improv
sequenc
depth
two
studi
describ
use
enrich
character
ebola
viru
kaposi
sarcomaassoci
herpesviru
use
illumina
truseq
rna
access
agil
sureselect
xt
target
enrich
respect
mate
et
al
olp
et
al
collect
strategi
result
increas
target
sequenc
read
improv
depth
coverag
sequencespecif
enrich
probe
also
use
studi
human
virom
bries
et
al
wyli
et
al
bries
colleagu
develop
virom
captur
sequenc
platform
vertebr
virus
author
design
million
viral
enrich
probe
target
viru
taxa
least
one
viru
known
infect
vertebr
bries
et
al
method
result
increas
number
target
viral
read
reduct
host
background
similarli
wyli
et
al
report
virocap
enrich
system
custom
panel
million
genusand
virusspecif
probe
target
vertebr
virus
famili
allow
viral
enrich
clinic
specimen
librari
studi
probe
design
target
known
sequenc
limit
identif
highli
diverg
virus
report
approach
targetbas
enrich
sensit
detect
broad
spectrum
respiratori
virus
ng
use
two
complementari
panel
oligonucleotid
probe
target
repres
common
respiratori
virus
proof
concept
virusspecif
probe
span
full
genom
common
respiratori
virus
conserv
viral
group
probe
target
conserv
region
nine
viral
famili
subfamili
associ
respiratori
diseas
virusspecif
probe
allow
full
genom
sequenc
contribut
complet
confid
identif
character
target
virus
conserv
viral
group
probe
enabl
detect
diverg
virus
potenti
recogn
novel
virus
within
known
viral
famili
combin
two
enrich
approach
expect
increas
number
usabl
read
per
sampl
per
sequenc
run
significantli
improv
sensit
valu
ng
viral
detect
discoveri
sequenc
character
set
enrich
probe
provid
signific
improv
increas
overal
rate
viru
detect
percent
target
viral
read
ptr
per
sampl
ng
first
evalu
enrich
virusspecif
probe
use
repres
refer
virus
viral
famili
associ
human
respiratori
diseas
supplement
tabl
prior
librari
prepar
determin
viru
load
c
realtim
pcr
assay
avail
viral
c
valu
rang
depend
avail
refer
viru
na
stock
c
valu
around
sampl
gener
two
parallel
librari
viral
na
templat
use
differ
sequenc
indic
allow
us
assess
sampl
without
enrich
sequenc
run
virusspecif
probe
pool
improv
detect
target
viru
refer
viru
na
test
compar
unenrich
match
except
viru
fig
overal
enrich
virusspecif
probe
result
median
increas
ptr
increas
rang
supplement
tabl
notabl
sampl
improv
ptr
follow
enrich
adv
hrv
rsv
rsv
five
repres
influenza
virus
one
influenza
b
byamagata
viru
fig
supplement
tabl
three
samplesadv
enrich
ptr
overal
linear
genom
coverag
depth
coverag
improv
dramat
sampl
gener
linear
genom
coverag
supplement
tabl
provid
suffici
sequenc
tabl
inform
confirm
viru
ident
enrich
adv
influenza
bvictoria
less
effici
ptr
fig
supplement
tabl
enrich
success
set
refer
viru
sequenc
librari
describ
also
use
test
effici
enrich
conserv
viral
group
probe
set
order
evalu
enrich
diverg
virus
conserv
viral
group
probe
set
includ
addit
refer
virus
human
anim
origin
experi
supplement
tabl
abl
detect
total
target
virus
enrich
sampl
major
virus
difficult
confirm
unenrich
match
fig
supplement
tabl
ptr
per
sampl
also
greatli
increas
follow
enrich
sampl
test
posit
found
ptr
ptr
ptr
follow
enrich
enrich
also
result
median
increas
ptr
rang
increas
across
famili
fig
supplement
tabl
notabl
enrich
conserv
viral
group
supplement
tabl
probe
set
result
detect
human
respiratori
virus
target
virusspecif
probe
well
addit
virus
target
virusspecif
probe
exampl
includ
middl
east
respiratori
syndrom
coronaviru
merscov
avian
infecti
bronchiti
viru
ibv
canin
parainfluenza
viru
simian
viru
canin
distemp
viru
cdv
colorado
tick
fever
viru
ctfv
bunyip
creek
viru
bcv
sever
avian
influenza
virus
fig
four
virusesbk
polyomaviru
bkv
mammalian
orthoreoviru
type
reo
epizoot
hemorrhag
diseas
viru
ehdv
great
island
viru
giv
enrich
import
consider
viral
genom
captur
protocol
affect
overal
sensit
viru
detect
ng
assess
rel
sensit
compar
highest
sampl
c
valu
posit
target
viral
read
linear
genom
coverag
enrich
virusspecif
probe
set
virus
variou
viral
load
fig
supplement
tabl
repres
refer
virus
select
coronavirina
adenovirida
pneumovirida
orthomyxovirida
familiessubfamili
adv
rsv
influenza
respect
prepar
librari
dilut
refer
viru
sampl
spike
equival
amount
human
rna
result
viral
c
rang
previou
experi
gener
parallel
independ
barcod
librari
use
viral
na
mixtur
order
compar
target
viral
read
without
enrich
sequenc
run
use
librari
abl
measur
detect
limit
follow
viral
genom
enrich
use
rel
read
count
threshold
base
empir
overal
barcod
contamin
rate
exclud
low
viral
read
due
potenti
barcod
contamin
sampl
low
number
viral
read
highest
number
read
obtain
sampl
viru
run
label
neg
supplement
tabl
determin
endpoint
detect
highest
sampl
c
posit
target
viral
read
endpoint
assess
prior
enrich
improv
endpoint
detect
describ
log
differ
two
use
virusspecif
probe
could
detect
viru
preenrich
sampl
c
postenrich
sampl
detect
viru
c
improv
endpoint
detect
compar
unenrich
sampl
fig
supplement
b
c
figur
sensit
enrich
hybrid
sampl
prepar
serial
dilut
refer
viral
nucleic
acid
spike
constant
amount
human
rna
prior
librari
prepar
frequenc
read
identifi
kraken
shown
bar
graph
sampl
without
enrich
h
hybrid
nh
nonhybrid
virusspecif
probe
enrich
b
conserv
viral
group
probe
enrich
sequenc
run
linear
genom
coverag
shown
c
sampl
enrich
diagon
stripe
without
enrich
white
virusspecif
probe
viral
c
averag
depth
coverag
shown
bar
graph
abbrevi
viru
name
list
supplement
tabl
tabl
conserv
viral
group
probe
observ
improv
detect
detect
c
postenrich
fig
supplement
tabl
observ
improv
detect
adv
c
rsv
c
influenza
c
use
virusspecif
probe
fig
supplement
tabl
conserv
viral
group
probe
enrich
least
improv
achiev
adv
c
influenza
c
log
rsv
c
fig
supplement
tabl
overal
result
highlight
enrich
strategi
result
robust
improv
rel
endpoint
sensit
viral
detect
ng
also
assess
improv
linear
genom
coverag
set
virus
use
virusspecif
probe
set
enrich
unenrich
sampl
linear
genom
coverag
decreas
rel
reduc
viral
load
fig
supplement
tabl
show
effect
enrich
genom
coverag
measur
fold
chang
coverag
unenrich
nonhybrid
enrich
hybrid
sampl
overal
linear
coverag
greatli
increas
enrich
sampl
increas
unenrich
sampl
supplement
tabl
addit
obtain
near
full
genom
coverag
rsv
adv
virus
top
two
viral
load
test
around
c
influenza
top
three
viral
load
test
around
c
genom
sequenc
inform
allow
us
confirm
individu
viru
ident
unenrich
sampl
observ
full
genom
coverag
sampl
except
influenza
full
genom
coverag
top
one
viral
load
test
around
c
fig
supplement
tabl
follow
valid
enrich
use
refer
sampl
proceed
test
enrich
na
collect
clinic
sampl
confirm
contain
known
virus
supplement
tabl
select
one
clinic
sampl
known
viral
infect
viral
familysubfamili
test
perform
two
set
enrich
probe
virusspecif
probe
probe
evalu
use
refer
virus
evalu
use
clinic
sampl
viral
load
avail
rang
c
valu
supplement
tabl
clinic
sampl
gener
two
parallel
separ
barcod
librari
assess
sampl
without
enrich
sequenc
run
observ
improv
rate
target
viru
detect
clinic
sampl
set
probe
compar
unenrich
sampl
fig
supplement
tabl
mani
virus
nearli
undetect
unenrich
specimensal
sampl
ptr
sampl
target
viral
read
supplement
tabl
virusspecif
probe
enrich
viral
read
clinic
sampl
test
fig
supplement
tabl
collect
virusspecif
probe
enrich
lead
median
increas
ptr
unenrich
rang
supplement
tabl
nearli
clinic
sampl
display
high
level
viru
sequenc
enrich
follow
hybrid
except
hrv
hrv
sampl
librari
test
enrich
virusspecif
probe
identifi
sampl
ptr
eight
sampl
supplement
tabl
ptr
one
sampl
ptr
two
sampl
rhinovirus
fail
enrich
effici
also
observ
overal
improv
averag
depth
coverag
clinic
sampl
enrich
well
linear
genom
coverag
clinic
sampl
except
hrv
sampl
less
effici
enrich
supplement
tabl
improv
genom
coverag
provid
sequenc
inform
need
confirm
viru
ident
case
coinfect
two
virus
differ
titer
could
issu
one
enrich
viru
satur
avail
read
obscur
detect
simul
situat
gener
experiment
mix
sampl
contain
two
virus
rsva
differ
titer
virus
sourc
bank
singleinfect
clinic
sampl
order
keep
comparison
rang
relev
clinic
paramet
one
mix
sampl
rsva
present
higher
viral
load
c
lower
viral
load
c
mix
sampl
present
higher
viral
load
c
rsva
lower
viral
load
c
observ
substanti
enrich
virus
sampl
although
lower
viral
load
virus
unsurpris
correspond
lower
viral
read
tabl
genom
coverag
affect
mix
sampl
genom
coverag
obtain
virus
sampl
tabl
conserv
viral
group
probe
observ
viral
read
enrich
clinic
sampl
test
lead
median
increas
ptr
unenrich
rang
supplement
tabl
unenrich
sampl
contain
ptr
contain
fewer
total
viral
read
follow
enrich
conserv
probe
set
observ
sampl
ptr
eight
sampl
ptr
six
sampl
ptr
three
supplement
tabl
sampl
fail
enrich
dramat
improv
detect
coronavirus
merscov
camel
cov
adenovirus
adv
c
adv
e
parvoviru
rotaviru
virus
test
picornavirus
paramyxovirus
pneumovirus
influenza
b
virus
fig
supplement
tabl
enrich
ineffici
clinic
sampl
known
infect
coronaviru
two
polyomavirus
fig
util
conveni
ngsbase
sequenc
routin
pathogen
detect
discoveri
hinder
abund
host
commens
na
result
reduc
sensit
viru
detect
ng
studi
show
greatli
improv
ngsbase
viru
detect
follow
enrich
viral
na
use
two
complementari
set
probe
test
viral
refer
clinic
sampl
virusspecif
probe
also
improv
linear
genom
coverag
greater
depth
inform
gain
increas
full
genom
sequenc
allow
detect
viral
mutat
minor
variant
may
prove
use
viral
transmiss
evolut
studi
notabl
observ
virusspecif
probe
effect
share
nucleotid
similar
probe
sequenc
consist
observ
hybridizationbas
captur
perform
bries
et
al
high
level
hybrid
stringenc
like
contribut
inabl
enrich
relat
virus
insuffici
sequenc
homolog
includ
member
picornaviru
famili
exampl
hrv
hrv
clinic
sampl
enrich
fig
match
nucleotid
ident
genom
sequenc
hrv
viru
strain
use
probe
design
hrv
viru
test
similarli
averag
match
nucleotid
ident
hrv
c
speci
use
probe
design
hrv
speci
test
base
partial
sequenc
avail
hrv
expect
observ
use
hmpv
probe
design
enrich
effici
viru
addit
virus
mammalian
orthoreoviru
type
epizoot
hemorrhag
diseas
viru
great
island
viru
enrich
conserv
viral
group
probe
set
enrich
failur
virus
could
due
probe
sequenc
issu
thu
conserv
probe
set
coronavirus
reovirus
may
need
optim
abil
obtain
highqual
genom
sequenc
major
benefit
use
method
linear
genom
coverag
percent
genom
sequenc
depth
sequenc
base
number
support
read
import
studi
demonstr
virusspecif
probe
enrich
significantli
improv
linear
genom
coverag
well
sequenc
depth
virus
c
valu
high
supplement
tabl
increas
depth
coverag
full
nearli
full
genom
make
viru
classif
accur
confid
everi
base
even
sampl
low
viral
load
low
linear
genom
coverag
sequenc
island
high
read
depth
scatter
along
genom
use
subsequ
pcr
fill
genom
gap
viru
classif
type
importantli
studi
show
conserv
viral
group
probe
capabl
detect
diverg
potenti
unknown
virus
design
focus
conserv
region
viral
genom
within
viral
famili
subfamili
genu
use
probe
result
full
genom
sequenc
allow
enrich
divers
collect
virus
includ
known
potenti
novel
virus
exampl
recent
discov
virus
merscov
camel
coronaviru
colorado
tick
fever
viru
bunyip
creek
viru
enrich
use
conserv
viral
group
probe
set
anoth
benefit
conserv
viral
group
probe
pool
requir
modest
number
oligonucleotid
probe
synthes
compar
million
probe
would
requir
enrich
broad
rang
virus
use
probe
abil
detect
broad
rang
virus
includ
known
potenti
novel
virus
associ
human
respiratori
diseas
significantli
reduc
cost
burden
pathogen
discoveri
effort
illumina
rna
access
librari
prepar
kit
use
pilot
studi
gener
librari
chemic
fragment
rna
thu
would
expect
enrich
dna
viru
sequenc
activ
transcrib
rna
accordingli
mani
dna
virus
eg
polyomavirus
parvovirus
includ
studi
enrich
effici
rna
virus
adenovirus
parvoviru
refer
sampl
fig
clinic
sampl
fig
enrich
effici
possibl
presenc
rna
transcript
dna
viru
genom
effort
way
evalu
altern
kit
work
well
rna
dna
virus
overal
studi
present
method
reduc
background
nois
improv
ng
sensit
ultim
reduc
cost
reduc
complex
ngsbase
viru
sequenc
unknown
sampl
complementari
pair
respiratori
probe
panel
abl
enrich
full
genom
commonli
known
respiratori
virus
enrich
key
signatur
diverg
novel
virus
simultan
sequenc
run
like
give
use
inform
use
commerci
avail
reagent
easytofollow
protocol
make
method
easili
adapt
varieti
laboratori
set
may
easili
autom
highthroughput
set
abl
enrich
virus
nine
famili
subfamili
associ
common
respiratori
infect
use
smaller
conserv
viral
group
probe
pool
contain
probe
observ
addit
probe
increas
conserv
viral
group
probe
pool
probe
decreas
effici
enrich
work
present
pilot
studi
base
select
repres
respiratori
virus
updat
virusspecif
probe
set
includ
probe
addit
respiratori
virus
updat
probe
work
well
expect
adapt
also
pave
way
larger
panel
includ
develop
pan
viral
probe
set
pan
viral
genom
enrich
taken
togeth
approach
describ
offer
effici
comprehens
method
har
power
ng
routin
laboratori
clinic
viru
detect
discoveri
enrich
ng
coupl
rapid
diagnosi
method
realtim
pcr
provid
power
comprehens
tool
outbreak
investig
known
unknown
infecti
etiolog
combin
refer
viru
sampl
clinic
specimen
use
studi
describ
supplement
tabl
clinic
specimen
respiratori
specimen
nasopharyng
swab
oropharyng
swab
lung
tissu
known
infect
select
previou
human
respiratori
etiolog
studi
deidentifi
nucleic
acid
extract
describ
one
refer
virus
human
anim
origin
test
familysubfamili
refer
virus
match
virus
use
virusspecif
probe
design
supplement
tabl
select
includ
coronavirus
adv
adv
pneumovirus
rsva
rsvb
hmpv
paramyxovirus
bocavirus
influenza
viru
achicken
hongkong
picornavirus
rhinoviru
hrv
case
match
unavail
therefor
select
closest
avail
virus
exampl
use
adv
place
adenoviru
probe
base
influenza
viru
select
serotyp
anew
caledonia
pandem
asydney
aavian
turkeyengland
aavian
duckhong
kong
influenza
b
viru
includ
byamagata
bvictoria
lineag
probe
base
na
extract
use
qiaamp
minelut
viru
spin
kit
qiagen
accord
manufactur
instruct
na
elut
nucleasefre
water
aliquot
store
rna
extract
human
lung
carcinoma
cell
line
atcc
use
trizol
ls
thermo
fisher
scientif
accord
manufactur
instruct
store
mixtur
volum
refer
viral
na
human
rna
made
provid
refer
sampl
known
hostviru
content
mixtur
refer
viru
na
ad
cellular
rna
final
concentr
mix
rna
rnase
p
c
around
viral
c
unless
avail
refer
viru
viral
c
higher
evalu
rel
sensit
enrich
refer
viru
na
first
serial
dilut
mix
constant
amount
rna
sampl
prepar
use
ratio
volum
na
extract
clinic
specimen
either
use
directli
undilut
spike
rna
describ
rtpcr
perform
use
either
agpathid
onestep
rtpcr
thermo
fisher
scientif
superscript
iii
onestep
rtpcr
system
platinum
taq
dna
polymeras
thermo
fisher
scientif
accord
manufactur
recommend
protocol
use
primer
probe
describ
previous
supplement
tabl
case
obtain
c
sampl
anoth
lab
avail
design
two
differ
complementari
panel
oligonucleotid
probe
virusspecif
probe
conserv
viral
group
probe
hybridizationbas
enrich
common
respiratori
virus
describ
virusspecif
probe
design
span
genom
tile
probe
target
select
common
respiratori
virus
supplement
tabl
previous
describ
dehor
et
al
prior
probe
design
select
viral
sequenc
mask
lowcomplex
sequenc
common
repetit
element
human
transcriptom
eg
transpos
element
probe
otherwis
cover
proteincod
sequenc
viral
genom
gener
tile
endtoend
design
except
case
mask
lowcomplex
repetit
sequenc
final
cocktail
oligonucleotid
gener
conserv
viral
group
probe
target
virus
associ
respiratori
diseas
supplement
tabl
design
use
algorithm
describ
previous
tong
et
al
taxon
group
sequenc
align
gener
conserv
region
among
genom
viral
famili
genu
avail
genbank
identifi
consensu
degener
sequenc
select
singl
strand
end
biotinyl
oligonucleotid
synthes
oligonucleotid
normal
pool
togeth
cocktail
total
conserv
probe
respiratori
viral
panel
gener
composit
conserv
enrich
probe
cocktail
includ
probe
member
adenovirida
coronavirina
orthomyxovirida
paramyxovirida
parvovirina
picornavirida
pneumovirida
polyomavirida
reovirida
number
oligonucleotid
shown
parenthes
librari
prepar
target
enrich
perform
use
truseq
rna
access
librari
prep
kit
current
truseq
rna
exom
kit
illumina
contain
reagent
librari
prepar
hybrid
dehor
et
al
briefli
ng
viral
na
mixtur
clinic
sampl
na
use
librari
prepar
librari
prepar
parallel
individu
indic
sequenc
without
hybrid
enrich
either
virusspecif
probe
conserv
probe
use
hybrid
enrich
manufactur
protocol
follow
follow
modif
firststrand
cdna
synthesi
perform
superscript
iii
revers
transcriptas
thermo
fisher
scientif
rather
superscript
ii
revers
transcriptas
thermo
fisher
scientif
cycl
use
first
pcr
code
exom
captur
oligonucleotid
replac
either
conserv
probe
virusspecif
probe
hybrid
use
conserv
probe
pmol
ng
librari
pmol
probe
use
multiplex
vari
four
eight
librari
per
hybrid
hybrid
use
virusspecif
probe
probe
mixtur
use
multiplex
vari
four
librari
per
hybrid
hybrid
conserv
virusspecif
probe
second
pcr
amplif
increas
cycl
cycl
